march 2024
Last week Alea was validated and approved within the WHODrug Vendor Programme for handling C3 format WHODrug data.
The approval within the WHODrug Vendor Programme by the Upsala Monitoring Centre ensures the correct implementation and handling of WHODrug Global data within Alea and related services.
#WHODrug
march 2021
#hackinSAS officially started! This #hackathon is all about creating a potentially viable product using #analytics to build a better world.
In partnership with Amsterdam UMC, Amsterdam Skills Centre (ASC), Gelre ziekenhuizen and FormsVision BV, #ITsPeople will be developing an automatic classification of the quality of a Laparoscopic Cholecystectomy (gallbladder surgery) based on video’s by deep learning. This #innovation can further enhance the quality of surgery and will contribute to the development of training programs.
1 feb 2021
Incorporating experts from the seven European comprehensive cancer centers belonging to the Cancer Core Europe (CCE) Consortium, along with an additional four non-CCE partners*, the EU-funded, multi-site project CCE Building Data Rich Clinical Trials (CCE-DART), has now launched.
Coordinated by VHIO’s Elena Garralda, CCE-DART seeks to become a groundbreaking example in driving a novel generation of clinical trials in the current era of precision oncology.
This pioneering project will develop interconnected tools to reduce the current complexity of investigator-initiated trials and better guide clinical decision-making by incorporating cutting-edge digital technologies and platforms.
Cancer Core Europe (CCE) Consortium Members:
– Vall d’Hebron Institute of Oncology, Barcelona, Spain.
– Karolinska Institute, Stockholm, Sweden.
– Cambridge Cancer Center, Cambridge, UK.
– National Center for Tumor Diseases, Heidelberg, Germany.
– Netherlands Cancer Institute, Amsterdam, The Netherlands.
– National Cancer Institute of Milan, Italy.
– Gustave Roussy Cancer Campus Grand Paris, Villejuif, France.
Non-CCE Members:
– Digital Experimental Cancer Medicine Team, Manchester, UK.
– The Hyve, Utrecht, The Netherlands.
– DataRiver, Modena, Italy.
– FormsVision, Abcoude, The Netherlands.
29 March 2019
FormsVision / ALEA Clinical is heading back to Birmingham for the next EDGE conference. Last year was a success and we are looking forward to meeting a lot of new people this year.
The EDGE International Conference – CONNECTED will take place on the 3rd and 4th April 2019 in Birmingham. The 2-day conference will focus on transferring new EDGE skills and practices to improve the efficiency of clinical research. With an extended emphasis on networking and collaboration, CONNECTED will entail greater opportunities to network and make lasting professional contacts. FormsVision / ALEA Clinical can be found during the conference on the Clinical Informatics Research Unit stand.
27 December 2018
During Christmas, most of the businesses all around the world, have a more quietly and less busy two weeks.
Unfortunately, this does not count for patients, suffering from diseases. And also not healthcare staff and healthcare suppliers that are needed, throughout 24/7 a day, 356 days per year.
As a company, operating in the clinical trial industry, we are not able to help these people directly. But we try our best to provide the best software to be used in clinical trials. We hope that by providing a good service in software, we indirectly have a very small part in the improvement of healthcare all around the world. That is what we aim for in 2019!
25 October 2018
Every March and October, the discussion about daylight saving time and the effects on the mental and physical health of people all around the world.
The idea behind the clock shift is to maximize sunlight, as days start to lengthen in the spring and then wane in the fall. The logic is that by springing forward and falling back, people add an hour of sunlight to the end of the work day. But the benefits of this change are controversial, and the shift can have measurable impacts on health. The conversation and discussion about not having a daylight saving time change yearly is being more and more heard.
These issues all a side; the ALEA software will automatically change to ‘winter time’, depending on which location the user of ALEA is located.
16 August 2018
One of ALEA’s prestigious functionalities is the scan integration. The DICOM viewer can be used in many different scenario’s, for example in the COLORIII Trial of the VUmc Amsterdam, the Netherlands.
See here what the study is about and how the scans helps in their randomized clinical trial comparing transanal and traditional laparoscopic TME for rectal cancer: https://bit.ly/2Im8BfN
08 June 2018
Several studies set-up in ALEA are about the quality of life of patients suffering from diseases. The module that is being used for this is called ePRO.
In the last couple of years, there has been growth in the request of the ePRO module in ALEA. This is an application allowing data entry by a patient rather than a clinician, e.g. patient diaries and quality of life questionnaires.
Using a quality of life questionnaire gives accurate patient information during the studies. But also after the treatments, the data gathered from the quality of life questionnaires can provide a complete insight in the patients mental and psychical health.
05 April 2018
Since the 5th of April 2018, ALEA Clinical is officially a escrow certified organisation. This certificate, handed out by Softwareborg, is concluded to ensure and secure the use of ALEA Clinical licensees.
At the 5th of April 2018, Emile van der Donk, CEO of ALEA Clinical signed the arrangement. Therefore we provide an escrow arrangement to interested licensees of ALEA Clinical.
An escrow agreement is a financial arrangement where a third party, in this case the company Softwareborg, holds and regulates payment of the funds required for our customer and ALEA Clinical.
01 March 2018
At the end of February, a great conference was organized by EDGE to bring together the members of the research community, allowing to share knowledge and best practice with the aim to enhance clinical research across the UK, Europe, Canada and beyond.
One of the invited keynote speakers was Emile van der Donk, CEO of ALEA Clinical. Emile presented ALEA where randomisation, eCRF and Drug Supply Management that come together in a single, affordable solution.
17 Januari 2018
It is very likely that you heard about the legislation of the European Union’s General Data Protection Regulation (GDPR), which will be effective from 25th MAY 2018. We as provider of ALEA Clinical software offer a new version ALEA 18.1 which is GDPR compliant. An upgrade to this version cost less and we offer a migration path from the current version that our clients use to the newest version of ALEA.
The GDPR replaces an older data protection directive and it carries provisions that require businesses and public entities to protect the personal data and privacy recorded. We from ALEA Clinical guide our customers trough the path where the software and agreements will be ‘GDPR proof’. Interested? Please don’t hesitate to contact us via the contact form.
18 novemer 2017
You can not always protect your employees, but since 18th November we can at least take care of the safety of our employees in the office. After following a course, almost the whole ALEA Clinical team is ‘In-house emergency service’ certified. Besides the fact that every company should have at least one person with this certificate for safety reasons, ALEA Clinical thought it would be good to always have several persons able to help in risky situations. And also, the whole team learned a lot about reanimation, first aid and putting out a fire.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.